Patient-related barriers to hypertension control in a Nigerian population

International Journal of General Medicine

Volumn 7, Issue , 2014, Pages 345-353

  Okwuonu, Chimezie Godswill ^a   Ojimadu, Nnamdi Ezekiel ^b   Okaka, Enajite Ibiene ^c   Akemokwe, Fatai Momodu ^c  

^a Nephrology Unit Department of Internal Medicine   (Nigeria)

^b Federal Medical Center Umuahia   (Nigeria)

^c UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Blood pressure; Diabetes mellitus; Knowledge of hypertension; Lifestyle modification; Medication adherence; Proteinuria

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO ILLNESS; AWARENESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CROSS-SECTIONAL STUDY; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; FINANCIAL DEFICIT; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NIGERIAN; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT PARTICIPATION; SUBURBAN POPULATION;

EID: 84903900784     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S63587     Document Type: Article

References (75)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455): 217-223.
2. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004; 22(1): 11-19.
3. Macgregor GA. Africa and salt-the need for action now. Paper presented at The Second Pan-African Meeting on Hypertension, International Forum for Hypertension Control and Prevention in Africa, May 12-13, 2007, Nairobi, Kenya.
4. Briganti EM, Shaw JE, Chadban SJ, etal. Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust. 2003; 179(3): 135-139.
5. International Conference for Cardiovascular Disease Control and Prevention in Africa. WHL Newsletter. 2003; 88: 3. Available at http: //www.worldhypertensionleague.org/Documents/newsletters/2003/whl88.pdf. Accessed February 24, 2014.
6. Akinkugbe OO. Noncommunicable Disease in Nigeria: Final Report of a National Survey. Lagos, Nigeria: Federal Ministry of Health and Social Services; 1997.
7. Ogunlesi A, Osotimehin B, Abbiyessuku F, etal. Blood pressure and educational level among factory workers in Ibadan, Nigeria. J Hum Hypertens. 1991; 5(5): 375-380.
8. Arogundade F, Sanusi A, Hassan M, Gbadegesin A, Olarinoye F, Otuyemi B. Undiagnosed hypertension and proteinuria in a market population in Ile Ife, Nigeria. Arab J Nephrol Transplant. 2011; 4(3): 141-146.
9. Oladapo OO, Salako L, Sadiq O, Shoyinka K, Adedapo K, Falase AO. A prevalence of cardiometabolic risk factors among a rural Yoruba South-Western Nigerian population; a population-based survey. Cardiovasc J Afr. 2010; 21(1): 26-31.
10. Ulasi Il, Ijoma CK, Onodugo OD. Community based study of hypertension and cardiometabolic syndrome in semi-urban and rural communities in Nigeria. BMC Health Serv Res. 2010; 10(71).
11. Ogah OS, Madukwe OO, Onyeonoro UU, etal. Cardiovascular risk factors and non-communicable diseases in Abia state, Nigeria: report of a community-based survey. Int J Med Biomed Res. 2013; 2(1): 57-68.
12. Onwubere BJ, Ejim EC, Okafor CI, etal. Pattern of blood pressure indices among the residents of a rural community in South East Nigeria. Int J Hypertens. 2011; 2011: 621074.
13. [No authors listed]. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 1997; 157(21): 2413-2446.
14. Berlowitz DR, Ash AS, Hickey EC, etal. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998; 339(27): 1957-1963.
15. Wang L, Wei T. Blood pressure control in patients with hypertension: a community-based study. Clin Exp Hypertens. 2006; 28(1): 41-46.
16. White F, Wang L, Jelinek H. Awareness and pharmacotherapy of hypertension in a rural community. Med Princ Pract. 2009; 18(4): 261-265.
17. Omuemu VO, Okogie OH, Omuemu CE. Awareness of high blood pressure status, treatment and Control in a rural community in Edo State. Niger J Clinical Pract. 2007; 10(3): 208-212.
18. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003; 21(11): 1983-1992.
19. Chobanian AV, Bakris GL, Black HR, etal. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6): 1206-1252.
20. Chalmers J, MacMahon S, Mancia G, etal. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens. 1999; 21(5-6): 1009-1060.
21. Odedosu T, Schoenthaler A, Vieira DL, Agyemang C, Ogedegbe G. Overcoming barriers to hypertension control in African Americans. Cleve Clin J Med. 2012; 79(1): 46-56.
22. Douglas JG, Ferdinand KC, Bakris GL, Sowers JR. Barriers to blood pressure control in African Americans. Overcoming obstacles is challenging, but target goals can be attained. Postgrad Med. 2002; 112(4): 51-52.
23. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001; 38(4): 809-814.
24. Chobanian AV. Control of hypertension-an important national priority. N Engl J Med. 2001; 345(7): 534-535.
25. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997; 95(4): 1085-1090.
26. Blumhagen D. Hypertension: a folk illness with a medical name. Cult Med Psychiatry. 1980; 4(3): 197-224.
27. Meyer D, Leventhal H, Gutmann M. Common-sense models of illness: the example of hypertension. Health Psychol. 1985; 4(2): 115-135.
28. Ogedegbe G, Mancuso CA, Allegrante JP. Expectations of blood pressure management in hypertensive African-American patients: a qualitative study. J Natl Med Assoc. 2004; 96(4): 442-449.
29. Lang T. Social and economic factors as obstacles to blood pressure control. Am J Hypertens. 1998; 11(7): 900-902.
30. Mehta SS, Wilcox CS, Schulman KA. Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP). Am J Hypertens. 1999; 12(4 Pt 1): 333-340.
31. Wang L. Physician-related barriers to hypertension management. Med Princ Pract. 2004; 13(5): 282-285.
32. Hicks LS, Shaykevich S, Bates DW, Ayanian JZ. Determinants of racial/ethnic differences in blood pressure management among hypertensive patients. BMC Cardiovasc Disord. 2005; 5(1): 16.
33. Hajjar I, Miller K, Hirth V. Age-related bias in the management of hypertension: a national survey of physicians' opinions on hypertension in elderly adults. J Gerontol A Biol Sci Med Sci. 2002; 57(8): 487-491.
34. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992; 82(12): 1607-1612.
35. Bone LR, Hill MN, Stallings R, etal. Community health survey in an urban African-American neighborhood: distribution and correlates of elevated blood pressure. Ethn Dis. 2000; 10(1): 87-95.
36. Wee LE, Koh GC. Individual and neighborhood social factors of hypertension management in a low-socioeconomic status population: a community-based case-control study in Singapore. Hypertens Res. 2012; 35(3): 295-303.
37. Isezuo AS, Njoku CH. Blood pressure control among hypertensives managed in a specialised health care setting in Nigeria. Afr J Med Med Sci. 2003; 32(1): 65-70.
38. Sani MU, Mijinyawa MS, Adamu B, Abdu A, Borodo MM. Blood pressure control among treated hypertensives in a tertiary health institution. Niger J Med. 2008; 17(3): 270-274.
39. Obinna IE, Patrick OU, Izuchukwu LN. Prevalence, awareness, treatment and control of hypertension in a Nigerian population. Health Psychol. 2010; 2: 731-735.
40. Oyati AI, Orogade AA, Danbauchi SS, Azuh PC. Awareness, treatment and control of hypertension among hypertensives in Zaria. Journal of Medicine in the Tropics. 2011; 13(2): 139-144.
41. Salako BL, Ajose FA, Lawani E. Blood pressure control in a population where antihypertensives are given free. East Afr Med J. 2003; 80(10): 529-531.
42. Iloh GUP, Ofoedu JN, Njoku PU, Amadi AN, Godswill-Uko EU. Medication adherence and blood pressure control amongst adults with primary hypertension attending a tertiary hospital primary care clinic in Eastern Nigeria. Afr J Prim Health Care Fam Med. 2013; 5(1): 446-452.
43. Araoye MO. Research Methodology with Statistics for Health and Social Sciences. Ilorin West, Nigeria: Nathadex Publishers; 2004.
44. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5): 348-354.
45. [No authors listed]. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979; 28(12): 1039-1057.
46. Giles WH, Kittner SJ, Hebel JR, Losonczy KG, Sherwin RW. Determinants of black-white differences in the risk of cerebral infarction. The National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med. 1995; 155(12): 1319-1324.
47. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997; 277(16): 1293-1298.
48. Ayodele OE, Alebiosu CO, Salako BL. Differential control of systolic and diastolic blood pressure in blacks with essential hypertension. J Natl Med Assoc. 2004; 96(3): 310-314.
49. Olanrewaju TO, Aderibigbe A, Chijioke A, etal. Descriptive analysis of blood pressure control among treated hypertensive patients in a tertiary hospital in Nigeria. Afr J Med Med Sci. 2011; 40(3): 207-212.
50. Cooper RS, Ordunez P, Ferrer MDI, Munoz JCB, Espinosa-Brito A. Cardiovascular disease and associated risk factors in Cuba: prospects for prevention and control. Am J Public Health. 2006; 96(1): 94-101.
51. Akpa MR, Alasia DD, Emem-Chioma PC. An appraisal of hospital based blood pressure control in Port Harcourt Nigeria. Nigerian Health Journal. 2008; 8(1-2): 27-30.
52. Wolf-Maier K, Cooper RS, Kramer H, etal. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004; 43(1): 10-17.
53. National Kidney Foundation. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013; 3(1): 19.
54. Davis TE, Millns H, Stratton IM, Holman RR, Turner RC, Group UKPDS. Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med. 1999; 159(10): 1097-1103.
55. Fagan TC, Sowers J. Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy. Arch Intern Med. 1999; 159(10): 1033-1034.
56. Green LW, Levine DM, Wolle J, Deeds S. Development of randomized patient education experiments with urban poor hypertensives. Patient Couns Health Educ. 1979; 1(3): 106-111.
57. Levine DM, Green LW, Deeds SG, Chwalow J, Russell RP, Finlay J. Health education for hypertensive patients. JAMA. 1979; 241(16): 1700-1703.
58. Iso H, Shimamoto T, Yokota K, Sankai T, Jacobs DR Jr, Komachi Y. Community-based education classes for hypertension control. A 1.5-year randomized controlled trial. Hypertension. 1996; 27(4): 968-974.
59. Okeahialam BN. Adherence and preference issues in anti-hypertensive therapy: experience from a private medical facility in Jos, Nigeria. Journal of Medicine in the Tropics. 2011; 13: 11-14.
60. Heurtin-Roberts S, Reisin E. The relation of culturally influenced lay models of hypertension to compliance with treatment. Am J Hypertens. 1992; 5(11): 787-792.
61. World Health Organisation. Essential Medicines and Health Products Information Portal. Adherence to long-term therapy-evidence for action. 2003. Available from: http: //apps.who.int/medicinedocs/en/d/Js4883e/6.1.1.html. Accessed February 21, 2014.
62. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5): 487-497.
63. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006; 12(3): 239-245.
64. Wang PS, Bohn RL, Knight E. Non-compliance with antihypertensive medications, the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002; 17(7): 504-511.
65. World Health Organisation. World health report on reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organisation; 2002. Available from: http: //www.who.int/whr/2002/en/. Accessed May 22, 2014.
66. Central Intelligence Agency. The World Factbook-Nigeria. May 2005. Available from: https: //www.cia.gov/library/publications/the-world-factbook/geos/ni.html. Accessed February 24, 2014.
67. Yarows SA, Julius S, Pickering TG. Home blood pressure monitoring. Arch Intern Med. 2000; 160(9): 1251-1257.
68. Johnson AL, Taylor DW, Sackett DL, Dunnett CW, Shimizu AG. Self-recording of blood pressure in the management of hypertension. Can Med Assoc J. 1978; 119(9): 1034-1039.
69. Mengden T, Uen S, Baulmann J, Vetter H. Significance of blood pressure self-measurement as compared with office blood pressure measurement and ambulatory 24-hour blood pressure measurement in pharmacological studies. Blood Press Monit. 2003; 8(4): 169-172.
70. [No authors listed]. Guidelines for the management of hypertension in Nigeria. May 1996. Available from: http: //www.nigerianheart.org/downloads/managementóf_hypertension.pdf. Accessed November 24, 2013.
71. Moore TJ, Conlin PR, Ard J, Svetkey LP. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension. 2001; 38(2): 155-158.
72. Appel LJ, Champagne CM, Harsha DW, etal. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003; 289(16): 2083-2093.
73. Ike SO, Aniebue PN, Aniebue UU. Knowledge, perceptions and practices of lifestyle-modification measures among adult hypertensives in Nigeria. Trans R Soc Trop Med Hyg. 2010; 104(1): 55-60.
74. Walsh JM, McDonald KM, Shojania KG, etal. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006; 44(7): 646-657.
75. Akpa MR, Agomuoh DR, Odia OJ. Drug compliance among hypertensive patients in Port Harcourt, Nigeria. Niger J Med. 2005; (14): 55-57.